2026 NPPES data Pain Medicine (Physical Medicine & Rehabilitation) Physician NPI 1528168622 M.D.
Verify on CMS →

MARK BOUFFARD, M.D.

Pain Medicine (Physical Medicine & Rehabilitation) Physician in PALM DESERT, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 218 beneficiaries · Pain Medicine (Physical Medicine & Rehabilitation) Physician avg: 1K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$1.2K
41 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK BOUFFARD, M.D. is a Pain Medicine (Physical Medicine & Rehabilitation) Physician ([object Object]) practicing in PALM DESERT, California with a Medicare Part D prescribing footprint of 2K claims across 218 beneficiaries — 15% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.2K across 41 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK BOUFFARD, M.D. reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 1,956 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK BOUFFARD, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK BOUFFARD, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 09/25/2006

NPI 1528168622

Primary specialty

Pain Medicine (Physical Medicine & Rehabilitation) Physician

Niche

1,626 US NPIs in this specialty

Medicare Part D claims

1,956 40% vs specialty avg

2023 prescription claims

Specialty avg: 1,401

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Pain Medicine (Physical Medicine & Rehabilitation) Physician compares to other specialties among California providers

California providers

Pain Medicine (Physical Medicine & Rehabilitation) Physician share within California

1. Pain Medicine (Physical Medicine & Rehabilitation) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pain Medicine (Physical Medicine & Rehabilitation) Physician share within California

Medicare quality performance — MIPS

MARK BOUFFARD, M.D.'s 2023 MIPS final score plotted against the Pain Medicine (Physical Medicine & Rehabilitation) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pain Medicine (Physical Medicine & Rehabilitation) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Pain Medicine (Physical Medicine & Rehabilitation) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BOUFFARD, M.D. is a Pain Medicine (Physical Medicine & Rehabilitation) Physician provider practicing in PALM DESERT, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1528168622. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BOUFFARD, M.D. appears in the CMS NPPES registry as a Pain Medicine (Physical Medicine & Rehabilitation) Physician provider holding M.D. credentials at 72650 FRED WARING DR, PALM DESERT, CA, 92260, with a listed phone of (760) 776-7999. NPI 1528168622 was issued on 09/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOUFFARD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,956 prescription claims written by this provider, covering 218 Medicare beneficiaries and totaling roughly $300K in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 68.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Pain Medicine (Physical Medicine & Rehabilitation) Physician is a narrow specialty nationwide, with 1,626 enrolled providers across 50 states and an average of 1,401 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

72650 FRED WARING DR
PALM DESERT, CA 92260

Provider Details

NPI 1528168622
Specialty Pain Medicine (Physical Medicine & Rehabilitation) Physician
Credentials M.D.
Gender Male
NPI Issued 09/25/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK BOUFFARD, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PAIN AND SPINE CENTER OF THE DESERT INC
PALM DESERT, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BOUFFARD, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK BOUFFARD, M.D.. To verify MARK BOUFFARD, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK BOUFFARD, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 1,956 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,956
Total Claims
$300K
Total Drug Cost
218
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,283
Total Day Supply
61,000
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$223K
Generic Drug Cost
$76K
Opioid Claims
1,332 (68.1% rate)

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.73
Gender Split
61% female / 39% male
Age Distribution
<65: 31, 65-74: 90, 75-84: 80, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
351
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
221
Oxycodone Hcl
167
Morphine Sulfate Er
Morphine Sulfate
126
Belbuca
Buprenorphine Hcl
78
Buprenorphine
62
Xtampza Er
Oxycodone Myristate
59
Gabapentin
54
Tizanidine Hcl
52
Tramadol Hcl
51

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pain Medicine (Physical Medicine & Rehabilitation) Physician Overview

How MARK BOUFFARD, M.D. fits within the Pain Medicine (Physical Medicine & Rehabilitation) Physician landscape nationally.

1,626
Pain Medicine (Physical Medicine & Rehabilitation) Physician Providers in US
50
States with Pain Medicine (Physical Medicine & Rehabilitation) Physician
1,401
Avg Claims per Provider

MARK BOUFFARD, M.D.'s 1,956 claims are above the specialty average of 1,401.

Nearby Pain Medicine (Physical Medicine & Rehabilitation) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BOUFFARD.

Compare Pain Medicine (Physical Medicine & Rehabilitation) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BOUFFARD, M.D.'s specialty?
MARK BOUFFARD, M.D. specializes in Pain Medicine (Physical Medicine & Rehabilitation) Physician and practices in PALM DESERT, California. Credentials: M.D..
How much does MARK BOUFFARD, M.D. prescribe under Medicare Part D?
In 2023, MARK BOUFFARD, M.D. wrote 1,956 Medicare Part D claims totaling $300K in drug costs for 218 beneficiaries.
What is MARK BOUFFARD, M.D.'s Medicare quality score?
MARK BOUFFARD, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK BOUFFARD, M.D. located?
MARK BOUFFARD, M.D. is located at 72650 FRED WARING DR, PALM DESERT, CA, 92260. Phone: (760) 776-7999.
What is MARK BOUFFARD, M.D.'s NPI number?
MARK BOUFFARD, M.D.'s National Provider Identifier (NPI) is 1528168622, issued on 09/25/2006.
Does MARK BOUFFARD, M.D. prescribe more brand-name or generic drugs?
MARK BOUFFARD, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $223K in brand drug costs.
Does MARK BOUFFARD, M.D. prescribe opioids?
Yes, MARK BOUFFARD, M.D. had 1,332 opioid claims in 2023 with an opioid prescribing rate of 68.1%.
How many Pain Medicine (Physical Medicine & Rehabilitation) Physician providers are there in the US?
There are 1,626 Pain Medicine (Physical Medicine & Rehabilitation) Physician providers across 50 states in the US. The average Pain Medicine (Physical Medicine & Rehabilitation) Physician provider writes 1,401 Medicare Part D claims per year.
What drugs does MARK BOUFFARD, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK BOUFFARD, M.D.'s most frequently prescribed drugs include Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BOUFFARD, M.D. accept Medicare?
MARK BOUFFARD, M.D. appears in CMS Medicare data with 1,956 Part D claims and 218 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BOUFFARD, M.D.'s credentials?
MARK BOUFFARD, M.D.'s NPI is 1528168622 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology